Ho et al. (87) reported that Mk-4 increases cyclic adenosine monophosphate and enhances glucose-stimulated insulin secretion in β-cells without causing hypoglycemia (a risk with traditional insulin secretagogues). The gene discussed is INS; the disease is Hypoglycemia.